Nyxoah (NYXH) Cash & Current Investments (2020 - 2025)
Nyxoah (NYXH) recorded quarterly Cash & Current Investments of $55.9 million in Q4 2025, up 14.83% quarter-over-quarter from $48.7 million in Q2 2025, and down 38.88% on a YoY basis from $91.4 million in Q4 2024.
Nyxoah (NYXH) Cash & Current Investments (2020 - 2025) Analysis & Trends
Nyxoah's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $55.9 million for Q4 2025.
- In Q4 2025, Cash & Current Investments fell 38.88% year-over-year to $55.9 million; the TTM figure through Dec 2025 stood at $55.9 million (down 38.88% YoY), while the FY2025 annual figure was $55.9 million, down 38.88% from the prior year.
- Cash & Current Investments was $55.9 million for Q4 2025 at Nyxoah, up from $48.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $25.7 billion in Q3 2022 to a low of $48.1 million in Q1 2024.
- Historically, Cash & Current Investments has averaged $1.8 billion across 5 years, with a median of $83.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 99.69% in 2023, then jumped 47.14% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $155.0 million in 2021, then plunged by 37.57% to $96.8 million in 2022, then sank by 35.8% to $62.1 million in 2023, then soared by 47.14% to $91.4 million in 2024, then tumbled by 38.88% to $55.9 million in 2025.
- The last three Cash & Current Investments figures came in at $55.9 million (Q4 2025), $48.7 million (Q2 2025), and $66.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.87 Mn |
| Jun 30, 2025 | 48.66 Mn |
| Mar 31, 2025 | 66.32 Mn |
| Dec 31, 2024 | 91.42 Mn |
| Sep 30, 2024 | 77.95 Mn |
| Jun 30, 2024 | 83.77 Mn |
| Mar 31, 2024 | 48.13 Mn |
| Dec 31, 2023 | 62.13 Mn |
| Sep 30, 2023 | 78.91 Mn |
| Jun 30, 2023 | 92.04 Mn |
| Mar 31, 2023 | 103.11 Mn |
| Dec 31, 2022 | 96.78 Mn |
| Sep 30, 2022 | 25.72 Bn |
| Mar 31, 2022 | 143.47 Mn |
| Dec 31, 2021 | 155.02 Mn |
| Dec 31, 2020 | 110.05 Mn |